Sleep Apnea Devices Market – Future Growth Dynamics & Global Leaders

Market Size Estimation:

Both top-down and bottom-up approaches were used to estimate and validate the total size of the sleep apnea devices market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

# The key players in the industry and markets have been identified through extensive secondary research

The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes

All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation:

After arriving at the overall market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments. In order to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both, the demand and supply sides, in the sleep apnea devices industry.

Download PDF Brochure@

Expected Revenue Growth:

The global sleep apnea devices market is expected to reach USD 7.5 billion by 2024 from USD 4.5 billion in 2019 at a CAGR of 10.7%. The major factors driving the growth of the sleep apnea devices market are primarily a large pool of undiagnosed sleep apnea patients, growing awareness about the ill effects of untreated sleep apnea, growing usage of oral appliances, technological advancements in sleep apnea devices, considerable venture capital funding, and an increasing number of companies venturing into sleep apnea and oral appliances markets.

Report Objectives:

 To define, describe, and measure the global market by type, end user, and region

To provide detailed information about major factors influencing market growth (such as drivers, restraints, growth opportunities, and challenges)

To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the global market

 To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players

To forecast the size of the market in North America, Europe, Asia Pacific (APAC), and the Rest of the world (RoW)

# To strategically analyze the market structure and profile key players and their core competencies3 in the global market

To track and analyze competitive developments such as service launches, expansions, acquisitions, partnerships & collaborations; in the market.

Restraint: High cost of CPAP machines:

In most developed countries, the cost of a CPAP device is either reimbursed or provided by medical insurance companies. The main reason for non-adherence is non-acceptance on the part of the patient, mainly due to the mask causing discomfort or claustrophobia. However, conditions are different in most developing countries, where insurance access is minimal and insurance companies usually do not cover the cost of a CPAP device.

In countries like India, CPAP is not covered by private insurance companies. Only some government employees are able to be reimbursed for CPAP therapy, and that too reimbursement ranges from 30% to 100% depending on the reimbursement rules of various government offices. CPAP is generally an out-of-pocket expense for most of the Indian population. This is a major limiting factor for therapy adoption in these countries.

Similar factors affect the CPAP compliance rate among patients in other South Asian countries as well. For instance, in Singapore, the cost of a CPAP machine is substantial, with an auto-titrating CPAP device costing between USD 1,100–USD 1,500 (1,500–2,000 SGD approximately), which would be nearly half the median monthly income of the average Singaporean worker. Thus, high CPAP device costs act as a restraining factor for the global sleep apnea devices market, especially in developing countries.

Request Sample Pages@

Home care settings/individuals projected to grow at the highest CAGR in the global sleep apnea devices market during the forecast period

On the basis of end user, the sleep apnea devices market has been segmented into sleep laboratories & hospitals and home care settings/individuals. The sleep laboratories & hospitals segment accounted for the largest share of the market in 2018, while home care settings/individuals end-user segment is projected to grow at the highest CAGR during the forecast period. This high growth is likely driven by factors such as the rising preference for home sleep testing by both patients and private insurance companies, along with the favorable reimbursement scenario for home sleep testing.

North America is expected to dominate the sleep apnea devices market during the forecast period

On the basis of region, North America accounted for the largest share of the global sleep apnea devices market in 2018, whereas, the Asia Pacific region registered the highest CAGR during the forecast period. North American accounted for the largest share owing to factors like an increase in the number of patients diagnosed with sleep apnea in the region, growth in awareness initiatives being taken by various government and non-government organizations, availability of adequate funding for research and development, and substantial growth in the usage of oral appliances in the region.

Key Players:

Major players operating in the sleep apnea devices market include ResMed (US), Koninklijke Philips (Netherlands), Fisher & Paykel Healthcare (New Zealand), SomnoMed (US), Oventus Medical (Australia), Compumedics (Australia), Löwenstein Medical (Germany), Drive DeVilbiss Healthcare (US), BMC Medical (China), Braebon Medical (Canada), and Panthera Dental (Canada).

Read More Detailed Report@